Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives

Abstract excerpt

Treatment-resistant schizophrenia (TRS) often results in severe disability and functional impairment. Currently, the diagnosis of TRS is largely exclusionary and emphasizes the improvement of symptoms that may not be detected early and treated according to TRS guideline. As the gold standard, clozapine is the most prescribed selection for TRS. Therefore, how to predict TRS in advance is critical for forming...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Receptor Mechanisms and Signaling
• Share to Schizophrenia research and treatment
• Share to Tryptophan and brain disorders